Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kalion
AddedFeb 15, 2024
UpdatedJun 18, 2026
Kalion

Kalion

Pre-Seed

Kalion, a biotech firm, manufactures high-purity chemicals with greener methods, replacing traditional oil-based molecules.

HQ
Milton, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Kalion, a biotech firm, manufactures high-purity chemicals using environmentally friendly methods to replace traditional oil-based molecules. Their products include glucaric acid and glucuronic acid, targeting markets such as industrial water treatment, pharmaceuticals, and materials improvement.

Kalion has achieved significant milestones in producing high-purity glucaric acid from biomass, offering sustainable alternatives in various industries. Their innovative approach has positioned them as a leader in green chemistry, contributing to more sustainable industrial practices.

Kalion - Similar Companies

Capra Biosciences logo

Capra Biosciences

Trillium Renewable Chemicals logo

Trillium Renewable Chemicals

GlycoSurf logo

GlycoSurf

glycosurf.com

Rivertop Renewables logo

Rivertop Renewables

Rennovia logo

Rennovia

GC Innovation America logo

GC Innovation America

Genomatica logo

Genomatica

genomatica.com

Amyris logo

Amyris

amyris.com

Biogenic Reagents logo

Biogenic Reagents

Dynamic Green Products logo

Dynamic Green Products

nvearth.com

Lygos logo

Lygos

lygos.com

Kultevat logo

Kultevat

kultevat.com

Greenyug logo

Greenyug

Carmolex logo

Carmolex

Kerogen Systems logo

Kerogen Systems

kerogensystems.com

Kalion - Quick Facts

Who are Kalion's competitors?

Companies similar to Kalion include Capra Biosciences, Trillium Renewable Chemicals, GlycoSurf and Rivertop Renewables.

When was Kalion founded?

Kalion was founded in 2011.

Where is Kalion's headquarters located?

Kalion's headquarters is located in Milton, MA, US.

When was Kalion's last funding round?

Kalion's most recent funding round was for $946.2k (USD) in June 2020.

How much has Kalion raised to-date?

As of Jun 18, 2020, Kalion has raised a total of $6.1M (USD).

How many employees does Kalion have?

Kalion has 12 employees as of Feb 5, 2024.

Kalion - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Biochemicals
  • Chemicals
Tags
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified